Cite
HARVARD Citation
Cram, P. et al. (2016). Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporosis international. 27 (12), pp. 3513-3524. [Online].